Genpact (G)
(Delayed Data from NYSE)
$38.95 USD
+0.47 (1.22%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $38.95 0.00 (0.00%) 4:38 PM ET
3-Hold of 5 3
A Value B Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$38.95 USD
+0.47 (1.22%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $38.95 0.00 (0.00%) 4:38 PM ET
3-Hold of 5 3
A Value B Growth C Momentum A VGM
Zacks News
Here's Why You Should Retain Fiserv (FISV) Stock for Now
by Zacks Equity Research
Strategic acquisitions and shareholder-friendly measures boost Fiserv (FISV). Meanwhile, low cash balance is a headwind.
Here's Why You Must Retain FLEETCOR (FLT) Stock for Now
by Zacks Equity Research
A strong top line and strategic acquisitions boost FLEETCOR (FLT). Meanwhile, low liquidity is a headwind.
6 Reasons Why It is Worth Betting on WEX for Your Portfolio
by Zacks Equity Research
Solid revenue growth and strategic acquisitions boost WEX.
Reasons Why You Should Bet on Charles River (CRAI) Stock Now
by Zacks Equity Research
Solid business diversification and investor-friendly moves aid Charles River (CRAI) stock.
Here's Why You Must Retain Equifax (EFX) Stock for Now
by Zacks Equity Research
Revenue growth, technology transformation and a wide range of industries boost Equifax (EFX). Meanwhile, low liquidity is a headwind.
Here's Why Investors Should Buy Republic Services (RSG) Now
by Zacks Equity Research
Investor-friendly steps and the growing adoption of recycling techniques boost Republic Services (RSG).
Here's Why a Hold Strategy is Apt for Trane Technologies (TT) Now
by Zacks Equity Research
Trane Technologies (TT) has a consistent record of rewarding its shareholders through dividend payments and share repurchases.
Here's Why You Must Retain FTI Consulting (FCN) Stock for Now
by Zacks Equity Research
Global business activities, investor-favorite endeavors and rising current ratio boost FTI Consulting (FCN). However, escalating expenses are a headwind.
Here's Why a Buy Strategy is Apt for Waste Management (WM) Now
by Zacks Equity Research
Waste Management (WM) continues to execute core operating initiatives targeting focused differentiation and continuous improvement.
Here's Why You Should Hold on to Green Dot (GDOT) Stock For Now
by Zacks Equity Research
Green Dot's (GDOT) long-standing relationship with Walmart remains a key driver of its operating revenues.
Here's Why You Should Retain Xerox (XRX) Stock for Now
by Zacks Equity Research
Post-sale-driven business model and strong margins boost Xerox (XRX). However, decreasing current ratio is a headwind.
Envestnet (ENV) to Benefit From Its Redi2 Buyout: Here's How
by Zacks Equity Research
The buyout makes Envestnet (ENV) one of the leading providers of revenue and billing tools required by advisors, wealth firms and asset managers.
Here's Why You Should Retain S&P Global (SPGI) Stock for Now
by Zacks Equity Research
Strategic buyouts as well as investor-favorite moves boost S&P Global (SPGI). However, decreasing current ratio is a headwind.
Xerox (XRX) to Benefit From Its Go Inspire Buyout: Here's How
by Zacks Equity Research
The acquisition should help Xerox (XRX) expand its Digital Services business and bring more innovation to its solutions.
Here's Why Investors Should Buy ICF International (ICFI) Now
by Zacks Equity Research
Strategic acquisitions and a strong balance sheet are aiding ICF International (ICFI) stock.
Reasons to Retain Maximus (MMS) Stock in Your Portfolio For Now
by Zacks Equity Research
With more than 40 years of experience, Maximus (MMS) has grown to be a leading operator of government health and human services programs globally.
6 Reasons to Add Paychex (PAYX) Stock to Your Portfolio Now
by Zacks Equity Research
Paychex's (PAYX) efforts to capitalize on the rising opportunities in the professional employer organization industry look impressive. Acquisitions help boost revenue growth.
G vs. PAYX: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
G vs. PAYX: Which Stock Is the Better Value Option?
Zacks Industry Outlook Highlights Automatic Data Processing, Paychex and Genpact
by Zacks Equity Research
Automatic Data Processing, Paychex and Genpact have been highlighted in this Industry Outlook article.
3 Stocks to Watch From the Promising Outsourcing Space
by Sanjana Goswami
The Zacks Outsourcing industry seeks to benefit from the coronavirus-driven dependency on technology and accelerated adoption of cloud infrastructure. ADP, PAYX and G are well-positioned to witness the surge in demand.
6 Reasons Why Investors Should Buy Genpact (G) Stock Now
by Zacks Equity Research
Acquisitions have helped Genpact (G) expand its portfolio and gain new domain expertise. Artificial Intelligence offers the company solid growth opportunities.
4 Reasons to Buy Cross Country Healthcare (CCRN) Stock Now
by Zacks Equity Research
Cross Country Healthcare (CCRN) is currently benefiting from its investments in headcount and technology.
G or PAYX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
G vs. PAYX: Which Stock Is the Better Value Option?
Why Genpact (G) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
G vs. PAYX: Which Stock Is the Better Value Option?
by Zacks Equity Research
G vs. PAYX: Which Stock Is the Better Value Option?